Table2 Multivariate Analysis of Risk Factors for Overall Survival
From: NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer
Characteristics | Hazard Ratio | 95%Confidence Interval | P-value |
|---|---|---|---|
Age(y) | |||
≤ 51 | 1 | ||
> 51 | 0.731 | 0.452 to 1.181 | 0.201 |
Pathological Gradig | |||
I/II | 1 | ||
III | 1.732 | 0.086 to 3.484 | 0.124 |
T stage | |||
T1/T2 | 1 | ||
T3 | 7.553 | 2.679 to 21.294 | 0.000 |
N stage | |||
N0 | 1 | ||
N1 | 1.591 | 0.801 to 3.162 | 0.185 |
M stage | |||
M0 | 1 | ||
M1 | 2.575 | 1.305 to 5.081 | 0.006 |
Clinical stages | |||
I/II | 1 | ||
III/IV | 11.814 | 4.312 to 32.365 | 0.000 |
NAP1L1 Status | |||
Low expression | 1 | ||
High expression | 2.045 | 1.145 to 3.657 | 0.016 |